Evidence map›Paper›PMID 39825921›Full record

ArticleJournal of cancer research and clinical oncology2025

Correction: Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic.

Volker Arndt, Daniela Doege, Stefan Fröhling, Peter Albers, Hana Algül, Ralf Bargou, Carsten Bokemeyer, Martin Bornhäuser, Christian H Brandts, Peter Brossart and 20 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cancer research and clinical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Impact of the COVID-19 pandemic on oncological care in Germany: rapid review.Journal of cancer research and clinical oncology · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Volker ArndtDivision of Clinical Epidemiology and Aging Research (C070), Unit of Cancer Survivorship (C071), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. v.arndt@dkfz-heidelberg.de.
Daniela DoegeDivision of Clinical Epidemiology and Aging Research (C070), Unit of Cancer Survivorship (C071), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Stefan FröhlingDivision of Translational Medical Oncology, German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Peter AlbersDepartment of Urology, Comprehensive Cancer Center, Center for Integrated Oncology (CIO Aachen, Heinrich Heine University Düsseldorf), Medical Faculty of the Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Hana AlgülComprehensive Cancer Center München, Institute for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich,, Munich, Bavaria,, Germany.
Ralf BargouComprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.
Carsten BokemeyerMedical Clinic and Polyclinic II, Center for Oncology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Martin BornhäuserMedical Clinic I, National Center for Tumor Diseases (NCT/UCC), University Hospital Carl Gustav Carus Dresden, TU Dresden, Dresden, Germany.
Christian H BrandtsUniversity Cancer Center (UCT) Frankfurt-Marburg, Frankfurt University Hospital, Frankfurt, Germany.
Peter BrossartMedical Clinic III and Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), University Hospital Bonn, Bonn, Germany.
Sara Yvonne BruckerComprehensive Cancer Center Tübingen-Stuttgart, Department of Women's Health, University Hospital Tübingen, Tübingen, Germany.
Tim H BrümmendorfMedical Clinic IV and Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), University Hospital of RWTH Aachen, Bonn, Aachen, Germany.
Hartmut DöhnerComprehensive Cancer Center Ulm (CCCU), Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
Norbert GattermannDepartment of Hematology, Oncology and Clinical Immunology, Comprehensive Cancer Center, Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), Medical Faculty of the Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Michael HallekClinic I for Internal Medicine, Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), University Hospital Cologne, Düsseldorf, Germany.
Volker HeinemannMedical Clinic and Polyclinic III, LMU Hospital, Munich, Germany.
Ulrich KeilholzCharité Comprehensive Cancer Center (CCCC), Berlin, Germany.
Thomas KindlerUniversity Cancer Center (UCT), University Medical Center Mainz, Mainz, Germany.
Cornelia von LevetzowClinic I for Internal Medicine, Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), University Hospital Cologne, Düsseldorf, Germany.
Florian LordickUniversity Cancer Center Leipzig and Department of Medicine II, University of Leipzig Medical Center, Leipzig, Germany.
Ulf Peter NeumannDepartment of Visceral and Transplantation Surgery, University Hospital of RWTH Aachen, Aachen, Germany.
Christoph PetersTumor Center Freiburg, Institute of Molecular Medicine and Cell Research, Freiburg, Germany.
Dirk SchadendorfWest German Tumor Center (WTZ) Essen and Clinic for Dermatology, Essen University Hospital, Essen, Germany.
Stephan StilgenbauerComprehensive Cancer Center Ulm (CCCU), Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
Thomas ZanderClinic I for Internal Medicine, Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), University Hospital Cologne, Düsseldorf, Germany.
Daniel ZipsComprehensive Cancer Center Tübingen-Stuttgart and Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.
Delia BraunGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Thomas SeufferleinGerman Cancer Society, Berlin, Germany.
Gerd NettekovenGerman Cancer Aid, Bonn, Germany.
Michael BaumannGerman Cancer Research Center (DKFZ), Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39825921
PMCPMC11742772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.